Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

“Waive intellectual property rights on drugs”

“Waive intellectual property rights on drugs”

THE African Union is backing calls for drugmakers to waive some intellectual property rights on COVID-19 medicines and vaccines to speed up their rollout to poor countries, the head of its disease control body said yesterday. South Africa and India, which both manufacture drugs and vaccines, made the proposal at the World Trade Organization last year, saying intellectual property (IP) rules were hindering the urgent scale-up of vaccine production and provision of medical products to some patients. They have faced opposition from some developed nations, but the backing of the African Union may give renewed impetus for the push to…
Read More
G20 says it will strive for fair global access to COVID-19 vaccine

G20 says it will strive for fair global access to COVID-19 vaccine

DAVIDE BARBUSCIA, MARWA RASHAD AND RAYA JALABI LEADERS of the 20 biggest economies have vowed to spare no effort to supply COVID-19 drugs, tests and vaccines affordably and fairly to "all people", reflecting worries that the pandemic could deepen divisions between the world's rich and poor. The pandemic and prospects of an uneven and uncertain economic recovery were at the centre of a two-day online summit under the chairmanship of Saudi Arabia, which will hand the G20 presidency to Italy next month. "The COVID-19 pandemic and its unprecedented impact in terms of lives lost, livelihoods and economies affected, is an…
Read More
India and South Africa ask WTO to waive rules to aid COVID-19 drug production

India and South Africa ask WTO to waive rules to aid COVID-19 drug production

INDIA and South Africa want the World Trade Organization (WTO) to waive intellectual property rules to make it easier for developing countries to produce or import COVID-19 drugs, a letter to the WTO shows. In their letter dated October 2 the two countries called on the global trade body to waive parts of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which governs patents, trademarks, copyright and other intellectual property rules globally. "As new diagnostics, therapeutics and vaccines for COVID-19 are developed, there are significant concerns (over) how these will be made available promptly, in sufficient quantities and…
Read More